Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer.
Clinical trial NCT02154776 · COMPLETED
Trial details
- NCT number
- NCT02154776
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-27
- Primary completion
- 2016-10-26
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.